PIK3CB and cancer: As a matter of fact that more than 50 PI3K inhibitors have been designed and produced for cancer treatment, but only a minority of them such as BKM120, XL147, XL765 and GDC-0084 have successfully entered into clinical trials for GBM treatment (https://clinicaltrials.gov, Table 2) [18].